Share Price and Basic Stock Data
Last Updated: February 16, 2026, 8:12 pm
| PEG Ratio | 4.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DMCC Speciality Chemicals Ltd operates within the specialty chemicals sector, focusing on production and sales of various chemical products. For the financial year ending March 2025, the company reported sales of ₹431 Cr, reflecting a notable increase from ₹387 Cr in the previous fiscal year. The trailing twelve months (TTM) sales reached ₹496 Cr, demonstrating a strong upward trajectory. The quarterly sales showed variability, with the highest recorded in March 2025 at ₹125.19 Cr, while the lowest was in December 2022 at ₹71.91 Cr. The company’s operational performance has been resilient, with an operating profit margin (OPM) of 13.53% for the TTM, indicating effective cost management and pricing strategies. Despite fluctuations in quarterly performances, the overall revenue trend suggests a recovery and growth potential, aligning with broader market demand for specialty chemicals, which is poised for expansion due to increasing applications across industries.
Profitability and Efficiency Metrics
DMCC has exhibited mixed profitability metrics, with a reported net profit of ₹22 Cr for the fiscal year 2025, significantly up from ₹7 Cr in fiscal 2023. The earnings per share (EPS) stood at ₹8.63 for the fiscal year 2025, a substantial increase compared to ₹2.78 in fiscal 2023, reflecting enhanced profitability per share. However, the company’s return on equity (ROE) was recorded at 9.45%, which is moderate compared to industry averages, indicating room for improvement. The interest coverage ratio (ICR) at 5.56x suggests that the company comfortably meets its interest obligations, although this is down from higher ratios in prior years. The cash conversion cycle (CCC) of 37 days indicates efficient management of working capital, suggesting that the company effectively converts its investments in inventory and receivables into cash flows.
Balance Sheet Strength and Financial Ratios
The company’s balance sheet reveals a solid financial position, with total borrowings reported at ₹40 Cr against reserves of ₹209 Cr, providing a favorable equity cushion. The debt-to-equity ratio stands at a low 0.20, indicating conservative leverage, which is advantageous in times of economic volatility. The book value per share has increased to ₹91.25, up from ₹84.02 in the previous year, reflecting retained earnings and capital growth. Moreover, DMCC’s current ratio of 1.23 suggests that it maintains sufficient liquidity to cover short-term liabilities. However, the price-to-book value (P/BV) ratio at 3.29x indicates that the stock may be trading at a premium relative to its book value, which could be a concern for value investors. Overall, the financial ratios suggest a well-managed balance sheet with a focus on sustainable growth.
Shareholding Pattern and Investor Confidence
The shareholding structure of DMCC reveals a strong promoter holding of 53.84%, which provides stability and confidence to investors. The public shareholding constitutes 44.49%, indicating a healthy level of retail investor participation. However, foreign institutional investors (FIIs) remain minimal at 0.39%, which could suggest limited international confidence in the stock. Domestic institutional investors (DIIs) hold 1.28%, reflecting cautious interest from larger financial entities. The number of shareholders has seen fluctuations, standing at 22,015 as of September 2025, suggesting a stable investor base. The consistent promoter holding combined with increasing retail participation may enhance market confidence, although the low institutional interest might raise questions regarding broader market sentiment toward DMCC.
Outlook, Risks, and Final Insight
Looking ahead, DMCC Speciality Chemicals Ltd is positioned to capitalize on the growing demand for specialty chemicals, driven by various sectors including agriculture, pharmaceuticals, and consumer goods. However, several risks remain, including potential fluctuations in raw material prices and global supply chain disruptions, which could impact profitability. The company’s moderate ROE suggests that enhancing operational efficiencies and expanding profit margins will be critical for sustaining growth. Furthermore, maintaining a balanced approach to leveraging while managing working capital will be essential for long-term financial health. The combination of strong promoter backing, a solid financial position, and improving profitability metrics provides a cautiously optimistic outlook, but vigilance regarding external market conditions and operational challenges will be crucial for future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 349 Cr. | 38.1 | 61.0/35.0 | 25.1 | 20.5 | 1.05 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.0 Cr. | 59.1 | 88.8/52.0 | 14.1 | 89.6 | 1.69 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.4 Cr. | 683 | 899/600 | 15.6 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,178 Cr. | 70.1 | 111/68.2 | 22.7 | 22.0 | 0.71 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 599 Cr. | 240 | 350/208 | 22.9 | 93.8 | 1.04 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,962.36 Cr | 733.20 | 84.09 | 182.87 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 104.71 | 71.91 | 96.50 | 85.57 | 76.52 | 80.53 | 83.95 | 85.32 | 102.70 | 118.03 | 125.19 | 127.02 | 126.02 |
| Expenses | 101.11 | 70.83 | 80.21 | 74.60 | 66.99 | 73.41 | 76.55 | 76.47 | 87.40 | 100.29 | 110.07 | 110.14 | 112.01 |
| Operating Profit | 3.60 | 1.08 | 16.29 | 10.97 | 9.53 | 7.12 | 7.40 | 8.85 | 15.30 | 17.74 | 15.12 | 16.88 | 14.01 |
| OPM % | 3.44% | 1.50% | 16.88% | 12.82% | 12.45% | 8.84% | 8.81% | 10.37% | 14.90% | 15.03% | 12.08% | 13.29% | 11.12% |
| Other Income | 0.40 | 0.91 | 0.77 | 0.88 | 0.81 | 0.67 | 9.29 | 0.21 | 0.31 | 0.39 | 0.44 | 0.37 | 0.30 |
| Interest | 1.84 | 3.16 | 3.29 | 3.47 | 2.88 | 3.56 | 3.85 | 3.01 | 2.77 | 2.53 | 2.19 | 2.03 | 1.91 |
| Depreciation | 4.92 | 4.80 | 4.54 | 3.55 | 3.90 | 3.91 | 4.33 | 4.16 | 4.25 | 4.25 | 4.03 | 4.19 | 4.11 |
| Profit before tax | -2.76 | -5.97 | 9.23 | 4.83 | 3.56 | 0.32 | 8.51 | 1.89 | 8.59 | 11.35 | 9.34 | 11.03 | 8.29 |
| Tax % | -0.00% | -45.23% | 27.63% | 34.99% | 33.71% | 6.25% | 32.20% | 26.46% | 32.36% | 30.57% | 30.73% | 29.74% | 30.64% |
| Net Profit | -2.77 | -3.28 | 6.68 | 3.14 | 2.36 | 0.29 | 5.78 | 1.39 | 5.80 | 7.88 | 6.47 | 7.75 | 5.75 |
| EPS in Rs | -1.11 | -1.32 | 2.68 | 1.26 | 0.95 | 0.12 | 2.32 | 0.56 | 2.33 | 3.16 | 2.59 | 3.11 | 2.31 |
Last Updated: February 2, 2026, 6:16 am
Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 126.02 Cr.. The value appears to be declining and may need further review. It has decreased from 127.02 Cr. (Jun 2025) to 126.02 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 112.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.14 Cr. (Jun 2025) to 112.01 Cr., marking an increase of 1.87 Cr..
- For Operating Profit, as of Sep 2025, the value is 14.01 Cr.. The value appears to be declining and may need further review. It has decreased from 16.88 Cr. (Jun 2025) to 14.01 Cr., marking a decrease of 2.87 Cr..
- For OPM %, as of Sep 2025, the value is 11.12%. The value appears to be declining and may need further review. It has decreased from 13.29% (Jun 2025) to 11.12%, marking a decrease of 2.17%.
- For Other Income, as of Sep 2025, the value is 0.30 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Jun 2025) to 0.30 Cr., marking a decrease of 0.07 Cr..
- For Interest, as of Sep 2025, the value is 1.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.03 Cr. (Jun 2025) to 1.91 Cr., marking a decrease of 0.12 Cr..
- For Depreciation, as of Sep 2025, the value is 4.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.19 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.08 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.29 Cr.. The value appears to be declining and may need further review. It has decreased from 11.03 Cr. (Jun 2025) to 8.29 Cr., marking a decrease of 2.74 Cr..
- For Tax %, as of Sep 2025, the value is 30.64%. The value appears to be increasing, which may not be favorable. It has increased from 29.74% (Jun 2025) to 30.64%, marking an increase of 0.90%.
- For Net Profit, as of Sep 2025, the value is 5.75 Cr.. The value appears to be declining and may need further review. It has decreased from 7.75 Cr. (Jun 2025) to 5.75 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.31. The value appears to be declining and may need further review. It has decreased from 3.11 (Jun 2025) to 2.31, marking a decrease of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 120 | 108 | 175 | 178 | 227 | 188 | 200 | 326 | 387 | 328 | 431 | 496 |
| Expenses | 86 | 101 | 91 | 145 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 433 |
| Operating Profit | 15 | 20 | 16 | 30 | 23 | 53 | 28 | 36 | 41 | 36 | 36 | 57 | 64 |
| OPM % | 15% | 16% | 15% | 17% | 13% | 24% | 15% | 18% | 12% | 9% | 11% | 13% | 13% |
| Other Income | 6 | -1 | 0 | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 2 |
| Interest | 2 | 2 | 1 | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 10 | 9 |
| Depreciation | 3 | 2 | 2 | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 17 |
| Profit before tax | 16 | 14 | 13 | 21 | 16 | 47 | 26 | 34 | 34 | 10 | 17 | 31 | 40 |
| Tax % | 0% | 0% | 9% | 21% | 21% | 2% | -22% | 4% | 37% | 35% | 33% | 31% | |
| Net Profit | 16 | 14 | 12 | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 28 |
| EPS in Rs | 7.55 | 6.58 | 5.63 | 7.79 | 4.92 | 18.47 | 12.63 | 13.06 | 8.56 | 2.75 | 4.64 | 8.64 | 11.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 10% | 8% | 0% | 15% | 6% | 0% | 22% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.50% | -14.29% | 41.67% | -29.41% | 283.33% | -32.61% | 6.45% | -36.36% | -66.67% | 71.43% | 83.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.79% | 55.95% | -71.08% | 312.75% | -315.94% | 39.06% | -42.82% | -30.30% | 138.10% | 11.90% |
DMCC Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 10% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -7% |
| 3 Years: | 1% |
| TTM: | 184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | -8% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -13 | 1 | 13 | 35 | 48 | 91 | 120 | 148 | 168 | 173 | 184 | 202 | 209 |
| Borrowings | 38 | 35 | 27 | 30 | 25 | 22 | 25 | 35 | 93 | 101 | 88 | 72 | 40 |
| Other Liabilities | 53 | 32 | 34 | 59 | 59 | 51 | 42 | 55 | 97 | 101 | 80 | 81 | 101 |
| Total Liabilities | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
| Fixed Assets | 26 | 24 | 26 | 83 | 87 | 99 | 101 | 108 | 174 | 230 | 238 | 234 | 226 |
| CWIP | 1 | 1 | 5 | 3 | 3 | 1 | 9 | 38 | 63 | 11 | 6 | 0 | 0 |
| Investments | 0 | 0 | 0 | 2 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 72 | 63 | 63 | 60 | 62 | 86 | 98 | 116 | 146 | 159 | 132 | 145 | 147 |
| Total Assets | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 209.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 209.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 40.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 72.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 32.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 101.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 374.00 Cr.. The value appears to be improving (decreasing). It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 226.00 Cr.. The value appears to be declining and may need further review. It has decreased from 234.00 Cr. (Mar 2025) to 226.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 145.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 374.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (209.00 Cr.) exceed the Borrowings (40.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -23.00 | -15.00 | -11.00 | 0.00 | -2.00 | 31.00 | 3.00 | 1.00 | -52.00 | -65.00 | -52.00 | -15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 44 | 44 | 45 | 45 | 48 | 48 | 58 | 56 | 49 | 51 | 63 |
| Inventory Days | 52 | 62 | 104 | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 |
| Days Payable | 126 | 76 | 115 | 129 | 114 | 79 | 68 | 116 | 131 | 121 | 119 | 84 |
| Cash Conversion Cycle | -12 | 29 | 33 | -25 | 4 | 49 | 93 | 94 | 3 | 6 | 13 | 37 |
| Working Capital Days | 15 | 1 | -7 | -37 | -6 | 43 | 80 | 32 | -5 | 2 | 5 | 16 |
| ROCE % | 34% | 34% | 24% | 35% | 21% | 43% | 18% | 19% | 16% | 7% | 8% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Diluted EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Cash EPS (Rs.) | 15.34 | 10.95 | 9.84 | 11.79 | 15.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Revenue From Operations / Share (Rs.) | 172.93 | 131.50 | 154.26 | 130.83 | 80.25 |
| PBDIT / Share (Rs.) | 23.40 | 18.73 | 15.55 | 18.48 | 17.35 |
| PBIT / Share (Rs.) | 16.70 | 12.43 | 8.49 | 15.25 | 14.61 |
| PBT / Share (Rs.) | 12.48 | 6.92 | 4.25 | 13.69 | 13.65 |
| Net Profit / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| NP After MI And SOA / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| PBDIT Margin (%) | 13.53 | 14.24 | 10.07 | 14.12 | 21.61 |
| PBIT Margin (%) | 9.65 | 9.45 | 5.50 | 11.65 | 18.20 |
| PBT Margin (%) | 7.21 | 5.26 | 2.75 | 10.46 | 17.00 |
| Net Profit Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| NP After MI And SOA Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| Return on Networth / Equity (%) | 9.45 | 5.53 | 3.49 | 11.02 | 18.81 |
| Return on Capital Employeed (%) | 15.38 | 11.47 | 7.88 | 15.10 | 18.68 |
| Return On Assets (%) | 5.66 | 3.07 | 1.72 | 5.56 | 12.35 |
| Long Term Debt / Equity (X) | 0.17 | 0.27 | 0.34 | 0.28 | 0.09 |
| Total Debt / Equity (X) | 0.20 | 0.31 | 0.40 | 0.40 | 0.14 |
| Asset Turnover Ratio (%) | 1.14 | 0.84 | 0.98 | 1.01 | 0.84 |
| Current Ratio (X) | 1.23 | 1.08 | 1.04 | 0.95 | 1.68 |
| Quick Ratio (X) | 0.84 | 0.66 | 0.63 | 0.64 | 1.13 |
| Inventory Turnover Ratio (X) | 9.95 | 4.03 | 5.48 | 5.09 | 2.94 |
| Dividend Payout Ratio (NP) (%) | 11.58 | 0.00 | 35.98 | 5.84 | 11.68 |
| Dividend Payout Ratio (CP) (%) | 6.52 | 0.00 | 10.16 | 4.24 | 9.65 |
| Earning Retention Ratio (%) | 88.42 | 0.00 | 64.02 | 94.16 | 88.32 |
| Cash Earning Retention Ratio (%) | 93.48 | 0.00 | 89.84 | 95.76 | 90.35 |
| Interest Coverage Ratio (X) | 5.56 | 3.40 | 3.67 | 11.84 | 18.03 |
| Interest Coverage Ratio (Post Tax) (X) | 3.05 | 1.84 | 1.66 | 6.48 | 14.57 |
| Enterprise Value (Cr.) | 789.57 | 745.75 | 677.05 | 982.66 | 815.55 |
| EV / Net Operating Revenue (X) | 1.83 | 2.27 | 1.76 | 3.01 | 4.07 |
| EV / EBITDA (X) | 13.53 | 15.96 | 17.46 | 21.32 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| Retention Ratios (%) | 88.41 | 0.00 | 64.01 | 94.15 | 88.31 |
| Price / BV (X) | 3.29 | 3.27 | 3.02 | 4.69 | 4.58 |
| Price / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
- For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
- For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 8. It has increased from 4.03 (Mar 24) to 9.95, marking an increase of 5.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.58. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 11.58, marking an increase of 11.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.52. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.52, marking an increase of 6.52.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.42, marking an increase of 88.42.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.48. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.48, marking an increase of 93.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 88.41. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.41, marking an increase of 88.41.
- For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DMCC Speciality Chemicals Ltd:
- Net Profit Margin: 4.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.38% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.45% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.84
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.9 (Industry average Stock P/E: 84.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Prospect Chambers, 317/321, Dr. Dadabhoy Naoroji Road, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Laxmikumar Narottam Goculdas | Chairman |
| Ms. Mitika Laxmikumar Goculdas | Vice Chairperson |
| Mr. Bimal Lalitsingh Goculdas | Managing Director & CEO |
| Mr. Kuldeep Kumar Tiwari | Executive Director - Operations |
| Mr. Mukul Manoharlal Taly | Ind. Non-Executive Director |
| Mr. Sanjeev Vishwanath Joshi | Ind. Non-Executive Director |
| Dr.(Mrs.) Janaki Ashwin Patwardhan | Ind. Non-Executive Director |
| Mr. Haren Devidas Parekh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of DMCC Speciality Chemicals Ltd?
DMCC Speciality Chemicals Ltd's intrinsic value (as of 17 February 2026) is ₹182.57 which is 23.93% lower the current market price of ₹240.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹599 Cr. market cap, FY2025-2026 high/low of ₹350/208, reserves of ₹209 Cr, and liabilities of ₹374 Cr.
What is the Market Cap of DMCC Speciality Chemicals Ltd?
The Market Cap of DMCC Speciality Chemicals Ltd is 599 Cr..
What is the current Stock Price of DMCC Speciality Chemicals Ltd as on 17 February 2026?
The current stock price of DMCC Speciality Chemicals Ltd as on 17 February 2026 is ₹240.
What is the High / Low of DMCC Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DMCC Speciality Chemicals Ltd stocks is ₹350/208.
What is the Stock P/E of DMCC Speciality Chemicals Ltd?
The Stock P/E of DMCC Speciality Chemicals Ltd is 22.9.
What is the Book Value of DMCC Speciality Chemicals Ltd?
The Book Value of DMCC Speciality Chemicals Ltd is 93.8.
What is the Dividend Yield of DMCC Speciality Chemicals Ltd?
The Dividend Yield of DMCC Speciality Chemicals Ltd is 1.04 %.
What is the ROCE of DMCC Speciality Chemicals Ltd?
The ROCE of DMCC Speciality Chemicals Ltd is 14.1 %.
What is the ROE of DMCC Speciality Chemicals Ltd?
The ROE of DMCC Speciality Chemicals Ltd is 9.97 %.
What is the Face Value of DMCC Speciality Chemicals Ltd?
The Face Value of DMCC Speciality Chemicals Ltd is 10.0.